{'fraction_non_alphanumeric': 0.02169035153328347, 'fraction_numerical': 0.005235602094240838, 'mean_word_length': 5.5268292682926825, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
PART 3: ELEVATED LEVELS OF THE SALIVARY PROTEIN IMMUNOGLOBULIN E, NERVE GROWTH FACTOR, MYOGLOBIN, AND INSULIN IN PATIENTS WITH TYPE 2 DIABETES OR WITH AUTOIMMUNITY CAN BE PREVENTED BY LT-10-TREATMENT

It is known that serum from allergy and asthma patients contains elevated levels of immunoglobulin E. This research reports use of a simple ELISA test for measuring levels of endogenous proteins, including immunoglobulin E, nerve growth factor, myoglobin, and insulin in non-invasively collected saliva. The elevated immunoglobulin E is believed to play a role in mediating symptoms of allergy/asthma, type 2 diabetes, and autoimmune diseases. High levels of immunoglobulin E were associated with increased glucose concentration and disruption of the regulation of levels of other endogenous proteins. Saliva from normal people and patients suffering from type 2 diabetes and various other disorders, such as autoimmune diseases, were assayed for immunoglobulin E, nerve growth factor, myoglobin, and insulin using a simple ELISA test employing the respective anti-sera. It was observed that saliva specimens from individuals with type 2 diabetes and various autoimmune diseases contained elevated levels of immunoglobulin E, nerve growth factor, myoglobin, and insulin in comparison with saliva samples from normal control individuals.